Dermpath Diagnostics is categorized under Primary Care Centers in Pittsburgh, PA and active since 2009.
Dermpath Diagnostics was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Tony Battistone, Manager at the company’s branch by writing to 5001 Center Avenue # 3, Pittsburgh, Pennsylvania PA 15213 or by phoning (412) 682-3083. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Dermpath Diagnostics |
Contact Person: | Tony Battistone, Manager |
Address: | 5001 Center Avenue # 3, Pittsburgh, Pennsylvania 15213 |
Phone Number: | (412) 682-3083 |
Website Address: | dermpathdiagnostics.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2009 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Primary Care Centers |
SIC Code: | 8011 |
NAICS Code: | 6215110 |
Share This Business: |
Dermpath Diagnostics was started in 2009 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Tony Battistone, Manager for inquiries that concern Dermpath Diagnostics by calling the company number (412) 682-3083, as your correspondence is most welcome. Additionally, the physical location of the branch of Dermpath Diagnostics can be found at the coordinates 40.45438,-79.944106 as well as the street address 5001 Center Avenue # 3 in Pittsburgh, Pennsylvania 15213.
For its online presence, you may visit Dermpath Diagnostics’s website at dermpathdiagnostics.com and engage with its social media outlets through on Twitter and on Facebook.